In situ detection of neural progenitor cells including stem-like cells is essential for studying the basic mechanisms of the generation of cellular diversity in the CNS, upon which therapeutic treatments for CNS injuries, degenerative diseases, and brain tumors may be based. We have generated rat monoclonal antibodies (Mab 14H1 and 14B8) that recognize an RNA-binding protein Musashi1, but not a Musashi1-related protein, Musashi2. The amino acid sequences at the epitope sites of these anti-Musashi1 Mabs are remarkably conserved among the human, mouse, and Xenopus proteins. Spatiotemporal patterns of Musashi1 immunoreactivity in the developing and/or adult CNS tissues of frogs, birds, rodents, and humans indicated that our anti-Musashi1 Mabs reacted with undifferentiated, proliferative cells in the CNS of all the vertebrates tested. Double or triple immunostaining of embryonic mouse brain cells in monolayer cultures demonstrated strong Musashi1 expression in Nestin(+)/RC2(+) cells. The relative number of Musashi1(+)/Nestin(+)/RC2(+) cells increased fivefold when embryonic forebrain cells were cultured to form 'neurospheres' in which stem-like cells are known to be enriched through their self-renewing mode of growth. Nestin(+)/RC2(-) cells, which included T·1-GFP(+) neuronal progenitor cells and GLAST(+) astroglial precursor cells, were also Musashi1(+), as were GFAP(+) astrocytes. Young neurons showed a trace of Musashi1 expression. Cells committed to the oligodendroglial lineage were Musashi(-). Musashi1 was localized to the perikarya of CNS stem-like cells and non-oligodendroglial progenitor cells without shifting to cell processes or endfeet, and is therefore advantageous for identifying each cell and counting cells in situ.
Introduction
Musashi1 is an RNA-binding protein encoded by musashi1, which was isolated as a mammalian homologue of the Drosophila Musashi (d-Msi) and cloned [1] . d-Msi is required for two successive asymmetric divisions of sensory organ precursor cells [2] . As it is expected that the generation of differentiated cells in mammals also occurs through asymmetric cell divisions in which two different types of daughter cells arise from a single progenitor cell, we have been studying whether mouse Musashi1 is involved in generating the diversity of cell types that give rise to mammalian organs.
Our previous investigations of Musashi1 expression in mice at both the mRNA and protein levels indicated that it is highly enriched in the developing CNS, where undifferentiated, proliferative cells generate a variety of cell types including neurons, astrocytes, and oligodendrocytes. Detailed immunolocalization studies with polyclonal antibodies produced by immunizing rabbits with mouse Musashi1 protein (polyclonal anti-Musashi1) demonstrated that immunoreactive cells were confined to zones where undifferentiated neural progenitor cells were situated [1, 3] , and that this polyclonal antibody also stained non-neuronal, progenitor-like cells in vitro [1] .
To elucidate the functions of Musashi1 in the developing vertebrate CNS, focusing on its possible involvement in generating the diversity of cell types, it is important to determine (1) which cells express Musashi1, and (2) whether it is expressed in the neural stem cells that have the most potential to generate different types of cells and to undergo asymmetric divisions. To this end, we have recently generated two monoclonal antibodies against Musashi1 that are specific for this protein, and do not cross-react with other Musashi1-related RNA-binding proteins.
Here, recently produced rat monoclonal antibodies to mouse Musashi1 were shown to recognize Musashi1 amino acid sequences that are highly conserved between frogs and humans. These monoclonal antibodies are therefore useful for experimental approaches that have been well established in lower animals such as amphibians and birds and also for clinical applications including the diagnosis of CNS-derived tumors or future trials in brain regeneration. Here, we also identified cells expressing Musashi1 as (1) neural stem cells, (2) neuronal progenitor cells, (3) astroglial progenitor cells, and (4) astrocytes.
Materials and Methods

Production of Anti-Musashi1 Monoclonal Antibodies
Musashi1 [1] and Musashi2 [Sakakibara et al., unpubl . data] proteins were prepared using pRSET-msi-1 and pRSET-msi-2 plasmid vectors, which were constructed by inserting the coding regions of the mouse Musashi1 and Musashi2 cDNA clones into pRSET (Invitrogen) with 6 tandem histidine residues at the 5)-cloning site. These plasmids were introduced into Escherichia coli strain BL21 (DE3) pLysS, and the expression of the fusion proteins was induced by incubating cells with IPTG (1 mM) for 4 h. Cells were harvested by centrifugation, and the fusion proteins were purified with Probond resin (Invitrogen) under denaturing conditions in buffer containing 8 M urea, as suggested by the manufacturer. Wistar rats were immunized with GST fusion Musashi1 protein, which was also used previously to raise polyclonal antibodies [1] . Hybridomas were generated by fusing spleen cells from immunized rats with a murine myeloma cell line P3X63Ag8U.I [4, 5] , and two independent clones, 14B8 and 14H1, were obtained. These rat monoclonal antibodies were purified by using protein G columns (MAbTrap GII; Pharmacia), and subtyped as IGg2b for 14H1 and IGg2a for 14B8 using a kit (Binding Site).
Epitope Mapping
To produce a series of C-terminal deletion mutants (Cdel-AFI) of mouse Musashi1 protein, cDNA fragments were cloned and amplified by PCR using pKF19k-T7msi [Imai et al., unpubl . data] as a template. A synthetic 5) PCR primer commonly used for full-length and mutant Musashi1 was 5)-CCCAAGCTTGCCACCATGGC-TAGCATGACTGGTGGAC-3), with a HindIII site, a kozac sequence, and a T7-tag sequence. A synthetic 3) PCR primer for fulllength musashi1 was 5)-GCTCTAGATCAGTGGTACCCATTGG-3), with an XbaI site and a stop codon. Nine other 3) primers were made, each with the same XbaI site and stop codon. Their complementary musashi1 sequences were as follows (the nucleotide (nt) number of the full-length musashi1 coding region is 1089): CdelA, nt 1015-1029; CdelB, nt 967-981; CdelC, nt 898-912; CdelD, nt 847-861; CdelE, nt 802-816; CdelF, nt 742-755; CdelG, nt 688-702; CdelH, nt 625-639; CdelI, nt 553-567. The PCR products were digested with HindIII and XbaI, and subcloned into the eukaryotic expression vector pCDNA3 (Invitrogen). These vectors were individually introduced into COS7 cells. Full-length and mutant Musashi1 proteins were collected and analyzed by immunoblotting with the monoclonal anti-Musashi1 antibodies.
Immunostaining of Tissue Sections
Xenopus and chick embryos were fixed by immersion in 4% paraformaldehyde in phosphate-buffered saline (PBS) (pH 7.4) overnight at 4°C, embedded in paraffin or OCT compound, and then sectioned (4-6 Ìm in paraffin sections; 10-12 Ìm in frozen sections). Mice and rats were perfused transcardially with 4% paraformaldehyde or Bouin's fixative. Brains were postfixed in the same fixative as used for perfusion overnight at 4°C, embedded, and sectioned. For plastic sections (1 Ìm), embryos were fixed with Zamboni's fixative overnight at 4°C, and specimens were embedded in Epon 812 [6] . Sections were treated with 0.3% hydrogen peroxide in methanol for 30 min to eliminate endogenous peroxidase activity and blocked with 5% BSA and 10% normal goat serum in PBS for 1 h at room temperature, then incubated with the following antibodies: mouse monoclonal anti-proliferating cell nuclear antigen (PCNA) (Novocastra Laboratories (1:200)); mouse monoclonal anti-Hu (16A11 [7] , a gift
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Dev Neurosci 2000; 22:139-153 141 from Dr. M.F. Marusich, University of Oregon (1:100 for Xenopus; 1:200 for chick, and 1:500 for rodents)); affinity-purified rabbit polyclonal anti-Musashi1 antibody [1] (1:500); rat monoclonal antiMusashi1 (14H1 (1:500 for rodents) or 14B8 (1:100 for Xenopus; 1:200 for chick, and 1:500 for rodents)); mouse monoclonal anti-Nestin (Rat 401 [8] [9] [10] , Hybridoma Bank (1:300)). Primary antibodies were applied overnight at 4°C followed by biotinylated secondary antibodies (all from Chemicon) for 1 h at room temperature, and visualized with diaminobenzidine using an ABC Kit (Vector). Anti-PCNA staining was performed after autoclaving cryosections in PBS at 110°C for 10 min. Double labeling with anti-Musashi1 and antiNestin, followed by anti-rat Cy3 and anti-mouse FITC (both from Chemicon), was examined with a confocal microscope (Carl Zeiss LSM510). Otherwise, specimens were examined using a universal microscope (Carl Zeiss, Axiophot 2). Digital images were taken with a CCD camera (Fujifilm, HC-2000 equipped with Photograb II software) and processed with Photoshop (Adobe) software.
Immunostaining of Cultured Cells
Cortical and striatal cells were isolated from E14 mouse embryos, and cultured on polyethyleneimine-coated coverslips in DMEM/F12 supplemented with 5% FBS. Some cells were fixed in 4% paraformaldehyde and immunostained shortly after plating, then additional cells were fixed every day until 10 days in vitro, and at 2 and 3 weeks. Primary antibodies used simultaneously with anti-Musashi1 (14H1, rat IgG (1:300)) were: (i) anti-Nestin (mouse IgG Rat 401 (1:300), and a rabbit polyclonal antibody against 10 amino acids in the Cterminus of mouse Nestin, from Dr. K. Yoshikawa, Osaka University (1:300)); (ii) RC2 [11] (mouse IgM, from Dr. M. Yamamoto, University of Tsukuba (1:5)); (iii) anti-GLAST [12] (rabbit antibody from Dr. M. Watanabe, Hokkaido University (3 Ìg/ml)); (iv) anti-GD3 [13, 14] (R24 mouse monoclonal IgM, from American Type Culture Collection (ATCC) (1:5)); (v) anti-MAP2 [15] (rabbit antibody, from Dr. M. Niinobe, Osaka University (1:1,000)), (vi) glial fibrillary acidic protein (GFAP) (rabbit antibody from Dako (1:10) and mouse IgG from Sigma (1:300)), and (vii) anti-green fluorescent protein (GFP) (rabbit antibody from Clontech (1:500)). Three different sets of triple labeling were performed as follows: (1) for the Musashi1/RC2/Nestin (polyclonal) or Musashi1/RC2/GLAST combinations, primary antibodies were applied to the cells as a cocktail, followed by a cocktail of Cy3-anti-rat IgG (mouse-absorbed, Chemicon), FITC-anti-mouse IgM (Ì-chain-specific; Jackson Immunoresearch), and AMCA-anti-rabbit (Jackson Immunoresearch) secondary antibodies (all at 1:100); (2) for the RC2/GLAST/GFAP (monoclonal) combination, GLAST and GFAP were visualized first, then cells were incubated with RC2 and its secondary antibody. Double labeling for Musashi1/MAP2, Musashi1/GFAP, and Musashi1/GD3 was performed similarly. We confirmed in separate samples that Nestin or GFAP could be detected in identical patterns using mouse or rabbit antibodies. Incorporation of 5-bromodeoxyuridine (BrdU) was tested by exposing cells to BrdU (10 ÌM ) for 1 h and immunostaining with anti-BrdU (mouse IgG; Sigma). In triple labeling for GFP/Musashi1/BrdU, cells were incubated simultaneously with anti-GFP and anti-Musashi1, then pretreated with HCl, and incubated with anti-BrdU. Antibodies were diluted in PBS containing 0.01% Triton X-100, and incubated with cells for 1 h at room temperature. Sphere cultures of E14-15 mouse striatal or cortical cells were prepared in the presence of epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF), according to previously described methods [16] [17] [18] [19] . The assays for self-renewal activity and multipotency were also performed as described [16] [17] [18] [19] . Human neurospheres were purchased from Clonetics Inc. and were maintained in medium with EGF and bFGF, as described [20, 21] . Both mouse and human neurospheres were whole-mount stained by incubating with anti-Musashi1 and anti-Nestin antibodies (the same concentrations as for monolayer cultures) in PBS with 0.2% Triton X-100 overnight. Cells dissociated from spheres were allowed to attach to coverslips, and immunostained as described for monolayer cultures.
Results
Preparation of Rat Monoclonal Anti-Musashi1 and Epitope Mapping
We previously demonstrated using Northern analysis that musashi1 mRNA is enriched in the developing mouse CNS [1] . Immunohistochemical examinations using polyclonal antibodies produced by immunizing rabbits with GST-fused Musashi1 protein (polyclonal antiMusashi1) show reactivity that is spatially and temporally consistent with the expression pattern of musashi1 mRNA [1, 3] . Recently, however, we isolated a mouse gene encoding a Musashi1-like RNA-binding protein, Musashi2 [S. Sakakibara and H. Okano, unpubl. data] , that is an orthologue of Xenopus Xrp1 [22] . Since mouse Musashi2 shows 82% amino acid identity to mouse Musashi1, polyclonal antibodies could detect both of these RNA-binding proteins. Thus, for more accurate expression analysis in situ, we have recently generated rat monoclonal antibodies to Musashi1.
Two rat monoclonal antibodies (Mab 14H1 and 14B8) were screened and used further for epitope mapping and specificity determination. For epitope mapping, a T7-tagged full-length mouse Musashi1 protein composed of 362 amino acids and a series of truncated proteins deleted from the C-terminus containing amino acids 1-343 (Cdel A), 1-327 (Cdel B), 1-304 (Cdel C), 1-287 (Cdel D), 1-272 (Cdel E), 1-252 (Cdel F), 1-234 (Cdel G), 1-213 (Cdel H), and 1-189 (Cdel I) were expressed in COS7 cells ( fig. 1A) . Binding of 14H1 and 14B8 to these proteins was tested by immunoblotting. Mab 14H1 detected the fulllength Musashi1 and mutants A through F, but not G through I, indicating its binding site to be between amino acids 235 and 362. Mab 14B8 detected only the fulllength Musashi1 and mutants A and B, indicating its binding site to be between amino acids 305 and 362. Furthermore, the GST-Musashi1 (full-length) fusion protein that had been used for the immunization was missing two parts of the amino acid sequence (245-268 and 287-297, marked with broken lines in fig. 1A ) due to alternative Kaneko/Sakakibara/Imai/Suzuki/ Nakamura/Sawamoto/Ogawa/Toyama/ Miyata/Okano splicing [11] . These data demonstrate that the 14H1 epitope lies between the Musashi1 amino acids 235 and 244 (LAPGYTYQFP) and the 14B8 epitope is located between amino acids 305 and 327 (GGFLGTTSPGPMAE-LYGAANQDS), as shown by the shaded regions in figure 1A.
The amino acid sequence at both of these epitope sites is highly conserved among Musashi1 orthologues in human [23] , mouse [1, 3] , and Xenopus (Nrp1) [24] (fig. 1A ), suggesting that Mab 14H1 and 14B8 can be used for immunohistochemical studies in various animal species. It also implies, however, that these Mabs might detect other Musashi1-like RNA-binding proteins such as mouse Musashi2 or Xenopus Xrp1 [22] . We therefore examined whether 14H1 and 14B8 specifically recognize Musashi1 without cross-reacting with Musashi2. In Western blot analysis, Mab 14H1 and 14B8, as well as the rabbit polyclonal anti-Musashi1 used in our previous studies [1, 3] , were applied to bacterially produced, His-tagged mouse Musashi1 and Musashi2 proteins ( fig. 1B ). Polyclonal anti-Musashi1 reacted with both of them, whereas Mabs 14H1 and 14B8 reacted only with Musashi1 and not with Musashi2, confirming their specificity for Musashi1.
Musashi1 Immunoreactivity in the Developing CNS of Xenopus and Chick
Motivated by the fact that the epitope sequences recognized by Mab 14H1 and 14B8 are highly conserved, at least among human, mouse, and Xenopus, we examined whether these anti-Musashi1 monoclonal antibodies showed an immunoreactive pattern in developing Xenopus and chick embryos corresponding to the pattern seen in mice [1, 3; also in this paper].
In Xenopus embryos (stage 40), anti-Musashi1 (14B8) immunoreactivity was found in the neural tube ( fig. 2A ). The immunoreactive area, which was along the ventricle, was also labeled with anti-PCNA, indicating that the 14B8(+) cells were proliferative ( fig. 2B ). In the outer zone of the neural tube, neither Musashi1 nor PCNA was detected, but another RNA-binding protein, Hu, which is known to be expressed in differentiating neurons [1, 3, 7, 25] , was detected ( fig. 2C ). This particular relationship between the expression of Musashi1, PCNA and Hu was also found in the neural tube of chick embryos (stage 18) ( fig. 2D-F) . These results, showing anti-Musashi1 immunoreactivity in the proliferative zone of the developing brain of Xenopus and chick, are consistent with our observations in the embryonic mouse CNS using polyclonal anti-Musashi1 [1] , and using Mab 14H1 and 14B8 (see below).
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Musashi1 Immunoreactivity in the Developing and Adult Rodent CNS
Although our previous studies showed that anti-Musashi1 immunoreactivity was found in the proliferative zone of the developing mouse CNS [1, 3] and in neural progenitor-like cells in vitro [1] , the polyclonal anti-Musashi1 antibody that we used could have reacted with other molecules in addition to Musashi1. We therefore examined whether Mabs 14H1 and 14B8 produced the same staining pattern that was seen with the polyclonal antibody. We also examined whether Musashi1 was colocalized with Nestin, an intermediate filament protein expressed in neural progenitor cells [8] [9] [10] .
In the embryonic mouse CNS, the pattern of labeling with anti-Musashi1 monoclonal antibodies was essentially the same as with polyclonal anti-Musashi1 [1] . Mabs 14H1 and 14B8 strongly labeled the neuroepithelium at E9-10 without regional specificity. Musashi1 was expressed faintly and transiently in Hu-expressing cells in the differentiating areas including the anterior horn of the spinal cord, then became negative in these neurons ( fig. 3A, B) . Musashi1 immunoreactivity became confined to the ventricular zone as neurogenesis proceeded.
We performed comparative confocal microscopic analysis for the expression of Musashi1 and Nestin in the developing spinal cord (E15 rat). Nestin was mainly visualized as fibers or their bundles extending from the ventricular area to the pial surface and they were often interrupted, while Musashi1 displayed a more restricted distribution, to cells along or near the ventricular surface ( fig. 3C ). Although Nestin was detected in the same area as Musashi1, suggesting colocalization with Musashi1, it was not easy to identify each Nestin(+) cell in tissue specimens (see also fig. 4C ). In the cerebellum at P5-10, where the highest level of granule neuron generation occurs ( fig. 3D ), the expression of Musashi1 was very intense in the outer half of the external granule cell layer (EGL) and absent in the inner half, where postmitotic neurons are found [26] .
In the adult mouse brain, Musashi1 expression was detected in two regions where neurogenesis continues to occur into adulthood ( fig. 3E-G) . One such region is the ependymal/subventricular zone (SVZ), from which proliferative neuronal precursors are provided through the rostral migratory stream (RMS) to supply new interneurons to the olfactory bulb [27] [28] [29] [30] [31] [32] [33] [34] . Musashi1 was detected in . C Confocal microscopic analysis of an E15 rat spinal cord section stained with monoclonal anti-Musashi1 (14H1, red) and polyclonal anti-Nestin (green). Musashi1(+) cell bodies were confined to an area near the central canal, whereas Nestin was detected as fiber bundles from the area of the Musashi1(+) cell bodies toward the pial surface. See also figure 4A, C for further comparison of the subcellular localization of these two marker molecules. D Musashi1 expression in the mouse cerebellum at P5. Musashi1 was strongly expressed in granule cell precursors situated in the outer half of the external granular layer (EGL), but not detected in differentiating granule cells in the inner half of the EGL. Musashi1 was also detected weakly in cells in the deeper cortical zones including the Purkinje cell layer (Pu) and internal granule cell layer (IGL), most of which have small oval cell bodies with unipolar or bipolar processes and appear to be differentiating glial cells. E-G Musashi1 immunoreactivity in the adult mouse cerebrum. E Musashi1 immunostained sagittal section containing the most anterior part of the lateral ventricle (lv) and the surrounding parenchyma. Musashi1 was strongly expressed in cells along the lateral ventricle and those comprising the rostral migratory stream (RMS). F A magnified view of the posterior part of the same sagittal section presented in E. Musashi1 staining was observed in both ependymal cells (ep), which were ciliated and directly facing to the lateral ventricle (lv), and cells in the subventricular zone (svz). In the dentate gyrus (G), Musashi1(+) cells with irregular oblong nuclei were found in the subgranular zone (sg, arrowheads), corresponding to the site where cells responsible for neurogenesis have been found [36, 37] . There were also Musashi1(+) cells with astrocytic morphology (arrows) in other zones including the molecular layer (ml), granular layer (gl) and the hilus (h). Scale bars: A, B, D 20 Ìm; C, F, G 10 Ìm; E 50 Ìm.
Kaneko/Sakakibara/Imai/Suzuki/ Nakamura/Sawamoto/Ogawa/Toyama/ Miyata/Okano 3C ). Although RC2 sometimes showed a combination of Musashi1-like and Nestinlike patterns as in this panel, cell processes were generally more intensely stained than perinuclear areas. D Musashi1/RC2/GLAST triple labeling at day 2 of culture. Musashi1(+)/RC2(+) cells were subgrouped into GLAST(+) (asterisk) (about 40%) and GLAST(-) (arrowheads) (about 60%) fractions. Musashi1(+)/RC2(-)/ GLAST(+) cells (double arrowheads), which were not found at day 0, appeared first, and this fraction expanded thereafter (see E). E RC2/ GLAST/GFAP triple labeling at day 5. Images for GFAP and RC2 are superimposed. All three of these markers were colocalized with Musashi1 in separate but sister cultures at this stage (not shown). Three types of cells were distinguished: RC2(+)/GLAST(+)/GFAP(-) (designated as type '1'), RC2(-)/GLAST(+)/GFAP(-) ('2'), and RC2(-)/GLAST(+)/GFAP(+) ('3'). The type '1' population disappeared and the type '3' fraction expanded during further cultivation. F Musashi1/GFAP double labeling at day 20, when cultures had become glial-cell dominant with a loss of neurons. All GFAP(+) cells were Musashi1(+), with either cytoplasmic or nuclear staining, or both. Some of these Musashi1(+)/GFAP(+) cells were also GLAST(+) at this stage (not shown), but GLAST immunoreactivity became weaker during further incubation. About 40% of the Musashi1(+) cells were GFAP(-) (not shown). We could not find a correlation between the intracellular localization of Musashi1 (cytoplasmic vs. nuclear) and the expression of GFAP. G A superimposed image of Musashi1/GD3 double-stained cells at day 7. Cell populations positive for Musashi1 or GD3 were completely segregated from each other. On previous days, GD3 was detected in Musashi1(+) cells (not shown). H Musashi1/MAP2 double staining at day 0. Cells strongly positive for Musashi1 were always negative for MAP2, whereas MAP2(+) neurons were negative or, in some cases, very faintly stained with anti-Musashi1. I Musashi1/RC2/Nestin triple staining on neurospheres generated from E14 mouse striatal cells. Spheres were grown as described [16] [17] [18] [19] , and subjected to whole-mount immunostaining at day 7 in culture. Spheres were positive for all these markers. When dissociated, about 80-95% of the cells that formed spheres were Musashi1(+)/Nestin(+). RC2(+) cells were always positive for Musashi1 and Nestin, and occupied about 50-70% of the total cells. The anti-Nestin antibody used for staining the sphere in this panel was a rabbit polyclonal (from Dr. K. Yoshikawa), although the staining pattern presented here was reproduced using a mouse monoclonal antibody (Rat 401). J Musashi1/Nestin double staining on human neurospheres. Neurospheres formed by cells derived from human embryos (Clonetics) were simultaneously stained with anti-Musashi1 and Rat 401 anti-Nestin antibodies. Anti-Musashi1 but not Rat 401 stained human sphere-forming cells. Bar: A-D, F-H 15 Ìm; E 20 Ìm; I 50 Ìm; J 100 Ìm.
the ciliated cells directly facing the lateral ventricle and also in cells of another type, adjacent to the former but more deeply located ( fig. 3F ). The former are considered to be ependymal cells; the latter might correspond to the type B cells (astrocytes) demonstrated by Doetsch et al. [34] , considering that we observed GFAP immunoreactivity in Musashi1(+) cells in this region (data not shown). Cells comprising RMS were also Musashi1(+) (fig. 3E ). Ependymal Musashi1 staining was also seen in the spinal cord (not shown). In the hippocampal dentate gyrus, another region of adult neurogenesis [35, 36] , Musashi1(+) cells were found in the subgranular zone ( fig. 3G) , which has been reported to contain BrdU-incorporating, progenitor cells.
Although polyclonal anti-Musashi1 stains certain populations of neurons in the olfactory bulb, cerebral cortex, reticular nucleus, or deep cerebellar nuclei in the adult brain [3] , Mabs 14B8 and 14H1 did not show such reactivity. An exception was the supraoptic nucleus, where neuronal staining with these Mabs was detected (data not shown).
Musashi1 Immunoreactivity in Cultured Neural Progenitor Cells
Musashi1 immunoreactivity was almost completely confined to areas of active neurogenesis and gliogenesis in vivo, suggesting that Musashi1 is expressed in neural progenitor cells, including multipotent, stem-like cells, neuronal progenitor cells, and glial progenitor cells. To define the types of cells that express Musashi1, we used other known markers for neural cells in double or triple immunolabeling experiments on cultured cells harvested from mouse (E14-15) cortex or striatum. Antibodies used simultaneously with anti-Musashi1 included: (i) anti-Nestin, which recognizes an intermediate filament protein expressed in neural progenitor cells [8] [9] [10] ; (ii) RC2, a radial glial cell marker with undefined epitopes [11] ; (iii) anti-GD3 ganglioside, which labels germinal cells in the embryonic and postnatal brain [12] and immature oligodendrocytes [13] ; (iv) anti-GLAST, which recognizes a glutamate transporter protein in a population of radial glial cells and cells differentiating to astrocytes [14] , and (v) anti-microtuble-associated protein 2 (MAP2) [15] or TuJ1 [37, 38] , for the detection of differentiated neurons.
In addition to these reagents, we used GFP to identify progenitor cells with a developmental potential restricted to the neuronal lineage. A recent study using FACSmediated characterization of embryonic rat forebrain cells transfected with a DNA construct containing GFP under the T·1 promoter identifies progenitor cells committed to the neuronal lineage [39] . We have recently generated transgenic mice [40] carrying GFP driven by the T·1 promoter, a system essentially identical to that used in the study by Wang et al. [39] .
Kaneko/Sakakibara/Imai/Suzuki/ Nakamura/Sawamoto/Ogawa/Toyama/ Miyata/Okano Musashi1(+)/Nestin(+)/RC2(+) Cells At day 0 in culture, E14/15 striatal cells were categorized into at least three groups based on their level of Musashi1 immunoreactivity. The first group (designated as Group I) contained cells that were strongly positive for Musashi1. This group comprised about 40-50% of the total E14/15 cells examined. These strongly Musashi1(+) cells actively incorporated BrdU (added 1 h before fixation), confirming that they were proliferative ( fig. 4B) . About 30-50% of the Group I cells (10-20% of the total cells tested) were colabeled with anti-Nestin and RC2 ( fig. 4A, arrowheads) . At 2-3 days, these Musashi1(+)/ Nestin(+)/RC2(+) cells (subgrouped into I-A) had elongated processes and showed differential localization of these three markers. Musashi1 was predominantly localized to the cell bodies and was almost undetectable in the processes, where, in contrast, strong RC2 and anti-Nestin immunoreactivity was seen ( fig. 4C ). This finding is consistent with results obtained by immunohistochemistry on rat embryonic spinal cord with anti-Nestin and antiMusashi1 antibodies ( fig. 3C ). In a different set of triple labeling experiments using anti-GLAST antibody instead of anti-Nestin, only 40% of the Musashi1(+)/RC2(+) cells -which were probably also Nestin(+) and could therefore be regarded as Group I-A cells -were GLAST(+) at the start of culture (not shown). This lower frequency of GLAST expression in Musashi1(+)/RC2(+) cells might reflect that GLAST is expressed with a ventrodorsal gradient in vivo [12] .
Musashi1(+)/Nestin(+)/RC2(-) Cells
The remaining Musashi1(+) cells (50-70% of Group I cells and 20-35% of the total E14/15 cells at day 0) were Nestin(+)/RC2(-), and negative for MAP2 or TuJ1. This Musashi1(+)/Nestin(+)/RC2(-) subgroup (designated as Group I-B) was further divided into two fractions using markers for cells committed to either a neuronal or astroglial lineage. First, to examine whether Musashi1 was expressed in neuronal progenitor cells, striatal cells were harvested from E15 T·1-GFP mice, and double stained with anti-Musashi1 and anti-GFP. Cells at day 0 were treated with BrdU for 1 h before fixation, then triple stained with antibodies to Musashi1, GFP, and BrdU (we also confirmed that all T·1-GFP(+) cells were RC2(-) in separate cultures). Strong Musashi1 expression was detected in about 30-40% of the T·1-GFP(+) cells (data not shown). Some of the Musashi1(+)/T·1-GFP(+) cells had incorporated BrdU, indicating that at least these Musashi1(+)/T·1-GFP(+)/BrdU(+) cells were neuronal progenitor cells. fig. 4D ) were negative for GFAP ( fig. 4E, 'type 1') . Musashi1(+)/GLAST(+) cells that were negative for RC2 were first found after 2 days and increased in number thereafter ( fig. 4D, double arrowheads) . These GLAST(+)/ RC2(-) cells were initially negative for GFAP ( fig. 4E , 'type 2' cells) and became GFAP(+) after 4-5 days in culture ( fig. 4E , 'type 3' cells). Nestin was detected in most GFAP(+) cells early in culture, but these cells turned Nestin(-) in advanced cultures (not shown). From these results, it is likely that RC2(-)/Musashi1(+)/Nestin(+)/ GLAST(+)/GFAP(-) cells comprise a subset of intermediate progenitor cells in the astrocytic lineage. GFAP(+) astrocytes, which increased in number progressively and almost totally occupied the cultures after 2 weeks, were always Musashi1(+). Interestingly, however, staining was not uniform with respect to the intracellular localization of Musashi1 ( fig. 4F ). In these GFAP(+) cells, Musashi1 expression was detected not only in the cytoplasm, as in Nestin(+)/RC2(+) cells, but also in the nucleus. It is presently unclear how this localization is controlled, although the frequencies of cytoplasmic or nuclear staining (or both) do not seem to be fixed. We also found a population of Musashi1(+)/GFAP(-) (GLAST-negative as well) cells in cultures carried beyond 2 weeks (not shown).
Musashi1-Negative Cells
Musashi1 expression was also detected in postmitotic neurons identified with anti-MAP2 ( fig. 4H) , TuJ1, or antineurofilament (Group II), but its level was significantly lower than that in the progenitor cells described above. These neurons appeared to be young and immature, based on their morphology in culture. Musashi1 was not detectable in mature neurons with long and thick processes (Group III, not shown). Cells committed to the oligodendroglial lineage also belonged to Musashi1 (-) Group III. In cultures maintained beyond 7 days, the Musashi1(+) and GD3(+) populations did not overlap ( fig. 4G) , although GD3 was colocalized with Musashi1 or Nestin in the starting E14-15 cells (not shown). Of the starting E14/15 forebrain cells, Group II and Group III cells made up about 30-40% and 10-20% of the total, respectively.
Musashi1 Expression in Stem-Like Cells in Culture
Since Musashi1 was expressed in both neuronal and astroglial progenitor cells, it is possible that Musashi1 is also expressed in the multipotent progenitor cells that generate these lineage-restricted progenitors. To examine this possibility, we used the neurosphere system, in which stem-like cells form spherical floating cell clusters ('spheres') as a consequence of their self-renewing proliferation in response to EGF and/or bFGF. Stem-like cells are therefore enriched in those spheres [16] [17] [18] [19] [20] [21] . By dissociating spheres to single cells and testing if those spherederived single cells can generate spheres again (passaging), the self-renewing activities of the cells in the original cell suspension can be analyzed. Similarly, by transferring spheres to a differentiation-permissive condition lacking EGF and bFGF ('differentiation assay') and using markers specific for neurons, astrocytes, and oligodendrocytes, we can test whether sphere-initiating cells in the starting cell suspension were multipotent.
Striatal and cortical cells from E14-15 mice were used for sphere cultures. Whole-mount immunostaining using anti-Musashi1, anti-Nestin, and RC2 antibodies demonstrated that these spheres were positive for these three markers ( fig. 4I ). However, it was unclear whether there were triple-positive cells, or if so, how much such triplepositive cells were contained in each sphere. We therefore examined the relative number of these triple-positive cells in spheres, by dissociating spheres and immunostaining the dissociated cells. Antibodies to Musashi1 or Nestin labeled 80-95% of the cells that formed spheres, while 50-70% were Musashi1(+)/Nestin(+)/RC2(+). This proportion of the triple-positive cells was up to 5 times greater than that seen in the starting E14/15 forebrain cells (10-20%), indicating that they were highly enriched in spheres. Spheres from the same culture were able to generate secondary spheres and a comparable proportion of triple-positive cells was seen in the secondary spheres, suggesting a self-renewing mode of cell growth in the Musashi1(+)/Nestin(+)/RC2(+) group. The primary spheres also generated neurons, astrocytes, and oligodendrocytes in differentiation assays, indicating multipotency of the initial sphere-producing cells. Although it remains unclear whether all of these Musashi1(+)/Nestin(+)/RC2(+) cells satisfy the above two criteria for neural stem cells in vitro, we conclude that our anti-Musashi1 monoclonal antibodies, together with anti-Nestin and RC2, recognize stem-like cells at least in vitro.
To test if we could apply the above findings to the identification of stem-like cells in vivo, we further examined temporal changes in the relative number of Musashi1(+)/ Nestin(+)/RC2(+) cells in vivo, as well as regional differences between the forebrain and other early differentiating regions, including the spinal cord. The proportion of triple-positive cells in the E12 forebrain (about 40-50%) was 2-3 times greater than that in the E14/15 forebrain (described above), and 3 times greater than that in the E12 spinal cord (about 15%). These data in vivo are consistent with the idea that Musashi1(+)/Nestin(+)/RC2(+) cells represent (or at least include) the most undifferentiated cells, which decrease in number as lineage commitment and cell differentiation proceed in the developing brain, and support our in vitro findings. We therefore propose that neural stem cells in the developing brain are Musashi1(+)/Nestin(+)/RC2(+).
We also tested whether our anti-Musashi1 monoclonal antibodies could be used for detecting stem-like cells in spheres derived from human embryonic brains. Human neurospheres were clearly stained with both of our monoclonal antibodies against mouse Musashi1, whereas Nestin was barely detectable with any of the available antibodies against rodent Nestin protein or synthetic peptides ( fig. 4J ).
Discussion
We generated monoclonal antibodies (Mabs) 14H1 and 14B8 against mouse Musashi1 and determined the amino acid sequences of their epitopes by immunoblot analysis using C-terminal deletion mutants of mouse Musashi1 ( fig. 1 ). The amino acid sequences at the epitope sites of these two monoclonal antibodies are almost identical to the corresponding sites of Musashi1 or its orthologues in Xenopus and humans. Therefore, our monoclonal antibodies to mouse Musashi1 can be widely used for detecting CNS progenitor cells in various species. Mabs 14H1 and 14B8 do not cross-react with a Musashi1-related protein, Musashi2, although rabbit 'polyclonal antiMusashi' (called 'polyclonal anti-Musashi1' earlier in this paper) recognizes Musashi2 ( fig. 1) . However, Musashi1 expression patterns detected with 14H1 or 14B8 are very similar to the pattern that we observed in our previous studies using the 'polyclonal anti-Musashi' [1, 3] , with minor exceptions in a few regions of the postnatal CNS.
Kaneko/Sakakibara/Imai/Suzuki/ Nakamura/Sawamoto/Ogawa/Toyama/ Miyata/Okano This may reflect that Musashi2 is expressed in a very similar pattern to Musashi1 [Sakakibara et al., unpubl. data] . Since Musashi1 and Musashi2 belong to the Musashi family of proteins, antibodies specific for each of these members are crucial tools for studying their respective expression and functions, both in normal animals and in mice in which one or more of them is disrupted.
Musashi1 Expression in Neural Stem Cells, Neuronal Progenitor Cells, Astroglial Progenitor Cells, and Astrocytes
Musashi1 is expressed in a spatiotemporal pattern that corresponds with active neurogenesis and gliogenesis in vivo ( fig. 2, 3 ). Musashi1-expressing cells in the embryonic CNS are proliferative (PCNA-positive and BrdUincorporating) ( fig. 2, 4B ) [1, 3] , and coexpress Nestin ( fig. 3C ) which is detected in neural progenitor cells [8] [9] [10] . Colocalization assays at the single cell level in culture ( fig. 4A-H Some Musashi1(+)/Nestin(+) cells were also positive for the RC2 epitope ( fig. 4A, C) , a marker for 'radial glial cells', which have been thought to be the earliest differentiated type of glial cells [11] . However, our examinations of temporal changes in the relative number of Musashi1(+)/Nestin(+)/RC2(+) cells in vivo suggest that these cells are the most undifferentiated. Furthermore, in neurosphere cultures, Musashi1(+)/Nestin(+)/RC2(+) cells comprise the largest cell population (at least 50-60% of the cells in each neurosphere), and spheres similarly formed in sister cultures can form new spheres and can also generate neurons, astrocytes, and oligodendrocytes. From these lines of evidence, we conclude that a considerable number of 'radial glial cells' can be regarded as stemlike cells, and that our monoclonal antibodies to Musashi1 detect CNS progenitor cells, from stem cells to progenitors committed to neuronal or astroglial lineage. Since Musashi1 is expressed predominantly in cell bodies, not in cell processes or endfeet where Nestin, GLAST, or RC2 epitope are distributed, and since Musashi1 shows no dorsoventral differences in its expression unlike GLAST [12] , Mabs to Musashi1 may provide a means for counting cells with better resolution than these markers.
Musashi1, RC2, Nestin, and GLAST, which are thought to be expressed in stem-like cells, are also expressed in cells that are differentiating into astrocytes ( fig. 4) . While the expression of RC2, Nestin, and GLAST terminates in this order (summarized in fig. 5 ), Musashi1 is expressed at all currently dissectable steps of astrocytic differentiation. Furthermore, Musashi1(+)/GFAP(-) cells with astrocytic morphology are found in both adult brains [3] and long-term cultures of embryonic brain cells (data not shown). Persistent expression of Musashi1 in mature, GFAP(+) astrocytes, and in GFAP(-) cells with an astrocytic morphology (presumptive protoplasmic astrocytes [3] ) as well, is remarkable among these examples of expression of stem cell markers in differentiating glial cells ( fig. 5 ). As shown in the adult brains of mice [3] and humans [41] , Musashi1 is expressed at the wall of lateral ventricles, where neurons are newly generated throughout life by stem cells. Although it is still controversial whether these stem cells are ependymal cells identified with S100/ Notch1 [42] or subependymal astrocytes expressing GFAP [43, 44] , both types of apparently differentiated cells express Musashi1 ( fig. 3E, F [46] [47] [48] , which are both more distally located toward the stem cells and away from the astrocytes, than Musashi1 is ( fig. 5 ). It can therefore be speculated that Musashi1 might be involved in the maintenance or reactivation of molecular machinery required by differentiated, quiescent glial cells to prepare for cellular events specific to neural stem cells. Such events could include asymmetric divisions or the regulation of neurogenic transcription factors. Further studies focusing on the function of Musashi1 as an RNA-binding protein in the process of neurogenesis and gliogenesis will lead to the elucidation of biological mechanisms that define or make cells become CNS stem cells.
Musashi1 Antibodies for Studying Neurogenesis in the Adult Brain
It has been known for more than two decades that neurogenesis occurs in adults of lower vertebrates, including fish, newts, salamanders and lizards, both during normal growth and in response to injury [49] [50] [51] [52] . Although these animals provide excellent experimental model systems for retinal regeneration [53] , the lack of versatile markers for neural progenitor cells has impeded the detailed dissection of the cellular and molecular mechanisms of this phenomenon. Recently, however, neural progenitor cells in the developing and regenerating retina of the newt have been well characterized using our 14B8 monoclonal antibody [Dr. Kazuto Kajiwara, pers. commun.]. Mab 14B8 has been used to demonstrate transdifferentiation of pigment epithelial cells to neural retinal progenitor cells. Further studies using this evolutionally conserved marker will help elucidate the basic mechanisms underlying neural regeneration in lower vertebrates.
Adult songbirds show active neurogenesis in the vocal control nucleus (high vocal center: HVC) [54, 55] . Neural progenitor cells in adult songbird brains [56] are detected with our monoclonal antibodies to mouse Musashi1. Anti-Musashi1 antibodies label both 'bipotential precursors' and 'radial cells' in the ependymal/subependymal zone of the song control nucleus HVC in a mediocaudal neostriatal region [S.A. Goldman, unpubl. results; reviewed in [57] .
Recent studies have drawn much attention to neurogenesis in the adult brain of mammals [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] including humans [20, 21, 41, 58] . Elucidation of the basic mechanisms regulating the activities of neural stem cells or lineage-restricted progenitor cells in more experimentally accessible lower animals through the use of reliable mark-Kaneko/Sakakibara/Imai/Suzuki/ Nakamura/Sawamoto/Ogawa/Toyama/ Miyata/Okano ers like Musashi1 will contribute information about neurogenesis in adult human brains.
Diagnostic Uses of Musashi1 Antibodies to Mark Brain Tumors
Musashi1 can also be used as a marker for human brain tumors or for differential diagnoses. The present study, as well as our previous reports [1, 3] on Musashi1 expression during brain development, have indicated that Musashi1 is expressed in neural progenitor cells (including EGL cells in the cerebellum), ependymal cells, and astrocytes, but not in neurons or oligodendrocytes. Consistent with this profile, Musashi1 expression is observed in specimens of medulloblastomas (which is known to originate from the EGL [59] ), ependymomas, glioblastomas, and astrocytomas, but not in oligodendrocytomas [Toda et al., and Kanemura et al., papers in preparation]. Furthermore, it has been found that the degree of Musashi1 expression in those tumors clearly show a positive relationship with the grade of the cancer at diagnosis, although its roles in tumor growth or determination remain to be elucidated.
